← Leaderboards
Beyza Bulutoglu
Massachusetts General Hospital
$63,154
Attributed
$63,154
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$63,154 · 1
By mechanism
F32$63,154 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Ralph Weissleder$110,468,710
- Livingston Van De Water$3,970,132
- Miles A Miller$6,082,715
- Caroline M Mitchell$7,369,880
- Ishir Bhan$684,180
Others in their field
Other Emerging Leaders on “Adjuvant”
- Ted Ross · University Of Georgia$68,763,143
- Jay Evans · University Of Montana$43,101,450
- Valerie Fremont · Quality Biological, Inc.$19,261,930
- Aaron Esser-Kahn · University Of Chicago$13,698,058
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$10,000,000
- Garcia-Sastre Adolfo · Icahn School Of Medicine At Mount Sinai$8,560,974
Research focus
AdjuvantAdvanced Glycosylation End ProductsAffectAngiogenesisAnti-InflammatoryAntimicrobialAntimicrobial PeptideAntimicrobial Peptide Ll-37BaseBehaviorBiologicalCathelicidinCell ProliferationCell SurvivalCharacteristicsChemokineChimeric ProteinsChronicChronic WoundClinically RelevantCostDecubitus UlcerDermalAcute